6 C.Wiśniewska et al.
Brodzka A, Koszelewski D, Ostaszewski R. 2012. The studies on
chemoenzymatic synthesis of Femoxetine. J Mol Catal B:
Enzymatic 82:96–101.
Brodzka A, Koszelewski D, wiklak M, Ostaszewski R. 2013.
Studies on the chemoenzymatic synthesis of 3-phenyl-GABA
and 4-phenyl-pyrrolid-2-one: the influence of donor of the
alkoxy group on enantioselective esterification. Tetrahedron:
Asymmetry 24:427–433.
which is close to the published value of Ϫ401.0 for
the optically pure (R,R)-enantiomer (Cheng et al.
2011).
Conclusions
Two different approaches to KR based on stereose-
lective enzyme-catalyzed esterification of racemic
carboxylic acid 1 and enzymatic hydrolysis of race-
mic ester 2 were applied.
Burton SG, Cowan DA, Woodley JM. 2002. The search for the
ideal biocatalyst. Nat Biotechnol 20:37–45.
Busto E, Gotor-Fernández V, Gotor V. 2010. Hydrolases: cata-
lytically promiscuous enzymes for non-conventional reactions
in organic synthesis. Chem Soc Rev 39:4504–4523.
Chan KH, Guan X, Lo VK, Che CM. 2014. Elevated catalytic
activity of ruthenium(ii)–porphyrin-catalyzed carbene/nitrene
transfer and insertion reactions with N-heterocyclic carbene
ligands. Angew Chem Int Ed Engl 53:2982–2987.
Charette AB, Janes MK, Lebel H. 2003. Bis(oxazoline)•copper(I)-
catalyzed enantioselective cyclopropanation of cinnamate esters
with diazomethane. Tetrahedron: Asymmetry 14:867–872.
Chen Y, Zhang XP. 2004. Vitamin B12 derivatives as natural
asymmetric catalysts: enantioselective cyclopropanation of
alkenes. J Org Chem 69:2431–2435.
Cheng K, Lee YS, Rothman RB, Dersch CM, Bittman RW,
Jacobson AE, Rice KC. 2011. Probes for narcotic receptor
mediated phenomena. 41. unusual inverse μ-agonists and
potent μ-opioid antagonists by modification of the n-substituent
in enantiomeric 5-morphans. J Med Chem 54:957–969.
Csuk R, Schabel MJ, von Scholz Y. 1996. Synthesis of the enan-
tiomer of the antidepressant tranylcypromine. Tetrahedron:
Asymmetry 7:3505–3512.
Davi M, Lebel H. 2008. One-pot approach for the synthesis of
trans-cyclopropyl compounds from aldehydes. Application to
the synthesis of GPR40 receptor agonists. Chem Commun
40:4974–4976.
KR of racemic trans-2-phenylcyclopropanecar-
boxylic acid via esterification was catalyzed by
hydrolases, but the desired product was obtained
with a low ee. The second approach was based on
enzymatic hydrolysis of ethyl trans-2-phenylcyclo-
propanecarboxylate, and the influence of enzyme
and solvent on enantioselectivity was examined. It
was found that the concentration of acetone used as
a cosolvent has a major impact on ee. Systematic
studies on the concentration of acetone on the ste-
reoselectivity of hydrolysis confirmed this result.
Optimized conditions to obtain product with a high
ee were established.The results expand the scope and
limitation of biocatalytic processes to solvent systems
containing predominantly organic solvents. These
reaction conditions may be applied in many biocata-
lytic processes, thereby increasing productivity.
We believe that the method elaborated will be of
considerable use, due to its simplicity.
Drauz K,Waldmann H, May O. 2012. Enzyme catalysis in organic
synthesis. Weinheim: Wiley-VCH. pp. 1–1985.
Elling GR, Hahn RC, Schwab G. 1973. Homoketenyl cations in
a friedel-crafts acylation. J Am Chem Soc 95:5659–5662.
Fryszkowska A, Komar M, Koszelewski D, Ostaszewski R. 2005.
Enzymatic desymmetrization of 3-arylglutaric acid anhydrides.
Tetrahedron: Asymmetry 16:2475–2485.
Ho CM, Zhang JL, Zhou CY, Chan OY, Jing Yan J, Zhang F,
Huang JS, Che CM. 2010. A water-soluble ruthenium glyco-
sylated porphyrin catalyst for carbenoid transfer reactions in
aqueous media with applications in bioconjugation reactions.
J Am Chem Soc 132:1886–1894.
Acknowledgement
This research was partially financed by Polpharma
Starogard Gdański, by project “Biotransformations
for pharmaceutical and cosmetics industry” no.
POIG.01.03.01–00-158/09–01 and by the European
Union in the frame of the COST Action CM1303.
Huber D, Kumar PGA, Pregosin PS, MikhelI S, Mezzetti A. 2006.
Declaration of interest: The authors report no
conflicts of interest. The authors alone are respon-
sible for the content and writing of the paper.
Chloro(η6-p-cymene)(phosphoramidite)ruthenium(II),
a
16-electron fragment stabilized by an η2-aryl–metal interac-
tion, and its use in asymmetric cyclopropanation. Helv Chim
Acta 89:1696–1710.
Kanchiku S, Suematsu H, Matsumoto K, Uchida T, Katsuki T.
2007. Construction of an aryliridium–salen complex for highly
cis- and enantioselective cyclopropanations. Angew Chem Int
Ed Engl 46:3889–3891.
Kazlauskas RJ, Bornscheuer UT. 1998. Biotransformations with
lipases. In: Rehm HJ, Reed G, eds. Biotechnology. Vol. 8a.
Weinheim: Wiley-VCH. pp. 37–191.
References
Andualema B, Gessesse A. 2012. Microbial lipases and their
industrial applications: review. Biotecnology 11:100–118.
Bornscheuer UT. 2002. Methods to increase enantioselectivity of
lipases and esterases. Curr Opin Biotechnol 13:543–547.
Bornscheuer UT, Kazlauskas RJ. 2006. Hydrolases in organic
Klibanov AM. 2001. Improving enzymes by using them in organic
solvents. Nature 409:241–246.
synthesis
– regio- and stereoselective biotransformations.
Hoboken, NJ: Wiley-Blackwell. pp. 1–368.
Knight J, Belcher P. 2005. 2-Aryl-5,5-bisoxazolin-2-yl[1,3]diox-
anes as solution phase and immobilised ligands for highly enan-
tioselective cyclopropanations. Tetrahedron: Asymmetry
16:1415–1418.
Koeller KM, Wong CH. 2001. Enzymes for chemical synthesis.
Nature 409:232–240.
Bouet A, Heller B, Papamica C, Dupas G, Oudeyer S, Marsaisa F,
LevacheV. 2007. Preparation of new axially chiral bridged 2,2′-
bipyridines and pyridyl monooxazolines (pymox). Evaluation in
copper(I)-catalyzed enantioselective cyclopropanation. Org
Biomol Chem 5:1397–1404.